![](/img/cover-not-exists.png)
Morin, a novel LXRα/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases
Gu, Ming, Zhang, Yu, Liu, Chuhe, Wang, Dongshan, Feng, Li, Fan, Shengjie, Yang, Baican, Tong, Qingchun, Ji, Guang, Huang, ChengLanguage:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.13933
Date:
June, 2017
File:
PDF, 1.63 MB
english, 2017